JPMorgan reduced its price target on Endava plc, while Morgan Stanley reiterated its Hold rating, both on August 29, 2025.
1 report, 1 independent
Updated Aug 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
JPMorgan reduced its price target on Endava plc, while Morgan Stanley reiterated its Hold rating, both on August 29, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Endava
British IT Company
-
JPMorgan Chase
American multinational banking and financial services holding company
-
Morgan Stanley
U.S. investment bank
- Morgan Stanley increased its price target for SLM Corporation on September 2, 2026.
- An offering was filed with the SEC on July 22, 2025, involving Simmons Bank, with joint book-running management from Stephens Inc., Keefe, Bruyette & Woods, and Morgan Stanley, and co-management from Robert W. Baird & Co.
Related events
- JPMorgan adjusted its price target on MetLife on July 8, 2025.
- JPMorgan Chase adjusted its price target for Cardinal Health on July 1, 2025.
- HSBC provided a buy rating and price target for Johnson & Johnson, while Morgan Stanley raised its price objective to $294.00. The company also filed required 13F reports with the SEC.
- DZ Bank lowered Apple's rating to hold, while Morgan Stanley set a target price for Apple shares on October 12, 2026.
- Morgan Stanley raised the price target and reaffirmed the rating for Johnson Controls International.
Coverage
Newest first; wire copies grouped- Insider MonkeyJPMorgan Reduces PT on Endava plc (DAVA); Morgan Stanley Reiterates ‘Hold’ Rating Endava plc (NYSE:DAVA) is one of the 12 Best Quantum Computing Stocks to Buy According to Wall Street Analysts. Endav